JP2002515864A - 造血性細胞増殖のペプチド阻害剤 - Google Patents

造血性細胞増殖のペプチド阻害剤

Info

Publication number
JP2002515864A
JP2002515864A JP52745097A JP52745097A JP2002515864A JP 2002515864 A JP2002515864 A JP 2002515864A JP 52745097 A JP52745097 A JP 52745097A JP 52745097 A JP52745097 A JP 52745097A JP 2002515864 A JP2002515864 A JP 2002515864A
Authority
JP
Japan
Prior art keywords
asp
lys
ser
pro
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP52745097A
Other languages
English (en)
Japanese (ja)
Inventor
テリー，ジョージャン
ジクザク―バカラ，ジョアンナ
ボーテェ，ピエール
ランファト，マリース
グリジョー，カトリーヌ
Original Assignee
ソシエテ ドゥ コンソイユ ドゥ ルシェルシュ エ ダプリカシオン シオンティフィック エス．アー．（エス．セ．エール．アー．エス．）
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ソシエテ ドゥ コンソイユ ドゥ ルシェルシュ エ ダプリカシオン シオンティフィック エス．アー．（エス．セ．エール．アー．エス．） filed Critical ソシエテ ドゥ コンソイユ ドゥ ルシェルシュ エ ダプリカシオン シオンティフィック エス．アー．（エス．セ．エール．アー．エス．）
Publication of JP2002515864A publication Critical patent/JP2002515864A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP52745097A 1996-02-01 1997-01-31 造血性細胞増殖のペプチド阻害剤 Pending JP2002515864A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US59536196A 1996-02-01 1996-02-01
US08/595,361 1996-02-01
US75451196A 1996-11-19 1996-11-19
US08/754,511 1996-11-19
PCT/IB1997/000221 WO1997028183A1 (fr) 1996-02-01 1997-01-31 Peptides inhibiteurs de la proliferation de cellules hematopoietiques

Publications (1)

Publication Number Publication Date
JP2002515864A true JP2002515864A (ja) 2002-05-28

Family

ID=27082249

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52745097A Pending JP2002515864A (ja) 1996-02-01 1997-01-31 造血性細胞増殖のペプチド阻害剤

Country Status (7)

Country Link
EP (1) EP0877753A1 (fr)
JP (1) JP2002515864A (fr)
AU (1) AU721261B2 (fr)
CA (1) CA2244673A1 (fr)
IL (1) IL125509A0 (fr)
PL (1) PL328081A1 (fr)
WO (1) WO1997028183A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008503555A (ja) * 2004-06-23 2008-02-07 サントル、ナショナール、ド、ラ、ルシェルシュ、シアンティフィク、（セーエヌエルエス） 少なくとも１種類の天然Ａｃ−Ｎ−Ｓｅｒ−Ａｓｐ−Ｌｙｓ−Ｐｒｏテトラペプチドまたはその類似体の１つの、皮膚老化防止および再構築剤としての美容的使用

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2814076B1 (fr) * 2000-09-21 2002-12-20 Centre Nat Rech Scient Agent angiogenique et ses utilisations
FR2882256B1 (fr) 2005-02-18 2007-05-25 Centre Nat Rech Scient Utilisation cosmetique d'au moins un tetrapeptide naturel ac-n-ser-asp-lys-pro- ou un de ses analogues en tant qu'agent pour ralentir la chute des cheveux et/ou stimuler leur croissance
KR101335203B1 (ko) 2010-03-26 2013-11-29 숙명여자대학교산학협력단 혈관신생촉진용 펩타이드 및 이의 용도
US9428552B2 (en) 2012-11-19 2016-08-30 Wellstat Therapeutics Corporation Stem cell mobilization and tissue repair and regeneration
FR3120794B1 (fr) 2021-03-16 2023-11-24 Rpm Dermatologie Composition pour injection comprenant un conjugué peptidique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601678B1 (fr) * 1986-07-18 1989-11-24 Inst Nat Sante Rech Med Peptides comprenant la sequence seryl-aspartyl-lysyl-prolyle, procede pour l'extraction du tetrapeptide correspondant, et applications, notamment a la protection de la moelle osseuse au cours de traitements anticancereux par la chimiotherapie
DE4224509C2 (de) * 1992-07-24 1995-04-20 Ruhenstroth Bauer Gerhard Prof Wirkstoff zur Hemmung der Proliferationsrate von Leberzellen

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008503555A (ja) * 2004-06-23 2008-02-07 サントル、ナショナール、ド、ラ、ルシェルシュ、シアンティフィク、（セーエヌエルエス） 少なくとも１種類の天然Ａｃ−Ｎ−Ｓｅｒ−Ａｓｐ−Ｌｙｓ−Ｐｒｏテトラペプチドまたはその類似体の１つの、皮膚老化防止および再構築剤としての美容的使用

Also Published As

Publication number Publication date
IL125509A0 (en) 1999-03-12
EP0877753A1 (fr) 1998-11-18
AU1807597A (en) 1997-08-22
CA2244673A1 (fr) 1997-08-07
WO1997028183A1 (fr) 1997-08-07
AU721261B2 (en) 2000-06-29
PL328081A1 (en) 1999-01-04

Similar Documents

Publication Publication Date Title
JP3159806B2 (ja) トロンビン阻害剤
EP1779859B1 (fr) Depsipeptide et congénères correspondants utilisés en tant qu'immunosuppresseurs pour la prévention et le traitement du rejet de greffe suite à une transplantation et pour l'induction d'une apoptose de lymphocytes T CD4 ou CD8 activés
EP2407478A1 (fr) Nouveaux cyclotetrapeptides ayant des propriétés pro-angiogenèse
EP1290011B1 (fr) Derives de melphalan et leur utilisation comme produits chimiotherapeutiques contre le cancer
JPH09511501A (ja) ２６ｓタンパク質分解複合体とその中に含まれる２０ｓプロテアソームの阻害剤
JPH0364514B2 (fr)
US6828302B1 (en) Therapeutic uses of depsipeptides and congeners thereof
EP0577775A1 (fr) Peptides et pseudopeptides antithrombotiques
US5332726A (en) Antithrombotic peptides and pseudopeptides
JPH04500666A (ja) ペプチド化合物
JP2002515864A (ja) 造血性細胞増殖のペプチド阻害剤
HU199879B (en) Process for producing hexapeptides and pharmaceutical compositions comprising same as active ingredient
RU2134695C1 (ru) Антитромботические азациклоалкилалканоилпептиды
US4552866A (en) Use of diamino alcohols as analgesic agents
WO2000044335A2 (fr) Derives d'antibiotiques du peptide uridylique (upa), leurs syntheses et utilisation
US4487764A (en) New peptides and a process for their preparation
HUT75538A (en) Oligopeptides derived from c-reactive protein fragments
US6992207B2 (en) Melphalan derivatives and their use as cancer chemotherapeutic drugs
US4670541A (en) Use of diamino alcohols as analgesic agents
EP1539803B1 (fr) Derives de fluoro-alkyl-cyclopeptide dotes d'une activite anti-integrine
EP4062974B1 (fr) Composition pharmaceutique pour la prévention ou le traitement du cancer
EP0672678A1 (fr) Dérivé d'azapeptide
JP2714425B2 (ja) ポリペプチド
US6274705B1 (en) Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
JP2004083427A (ja) 環状ヘキサペプチド及びプロテアソーム阻害剤